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PPRECLINICAL STUDIES
Left Ventricular Eccentric Remodeling and
Matrix Loss Are Mediated by Bradykinin and Precede
Cardiomyocyte Elongation in Rats With Volume Overload
Thomas D. Ryan, MD, PHD,* Emily C. Rothstein, PHD,* Inmaculada Aban, PHD,†
Jose A. Tallaj, MD,‡§ Ahsan Husain, PHD,*‡ Pamela A. Lucchesi, PHD,* Louis J. Dell’Italia, MD*‡§
Birmingham, Alabama
Objectives We hypothesized that left ventricular (LV) remodeling and matrix loss in volume overload (VO) are mediated by
bradykinin (BK) and exacerbated by chronic angiotensin-converting enzyme (ACE) inhibition.
Background Chronic ACE inhibition increases anti-fibrotic BK and does not attenuate LV remodeling in pure VO. The relative
contribution of changes in extracellular matrix versus cardiomyocyte elongation in acute and chronic LV chamber
remodeling during VO is unknown.
Methods Echocardiography, LV collagen content, and isolated cardiomyocytes were studied in rats after aortocaval fistula
(ACF) of 12 h, 2 and 5 days, and 4, 8, and 15 weeks. We also studied ACF rats after BK2 receptor (BK2R) block-
ade (2 days) or ACE inhibition (4 weeks).
Results At 2 days after ACF, LV end-diastolic dimension (LVEDD)/wall thickness was increased, and LV interstitial colla-
gen was decreased by 50% without cardiomyocyte elongation. The BK2R blockade prevented collagen loss and
normalized LVEDD/wall thickness. From 4 to 15 weeks after ACF, interstitial collagen decreased by 30% and left
ventricular end-systolic (LVES) dimension increased despite normal LVES pressure and isolated cardiomyocyte
function. The ACE inhibition did not decrease LVEDD/wall thickness, further decreased LV interstitial collagen,
and did not improve LV fractional shortening despite decreased LVES pressure.
Conclusions Immediately after ACF induction, eccentric LV remodeling is mediated by interstitial collagen loss without cardio-
myocyte elongation. Acute BK2R blockade prevents eccentric LV remodeling and improves function. Chronic ACE
inhibition does not prevent eccentric LV remodeling or improve function. These findings suggest that ACE inhibitor-
mediated increase in LV BK exacerbates matrix loss and explains why ACE inhibition is ineffective in VO. (J Am Coll
Cardiol 2007;49:811–21) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.06.083b
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ehen subjected to a volume overload, the mammalian left
entricular (LV) chamber dilates and remodels in an eccen-
ric manner. It is generally believed that eccentric remodel-
ng occurs by cardiomyocyte elongation and hypertrophy
hat serves to normalize left ventricular end-diastolic di-
ension (LVEDD) to wall thickness ratio (1). Eccentric
ypertrophy therefore accommodates the increased preload
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ffairs Medical Center, Birmingham, Alabama. Dr. Lucchesi is currently at the
epartment of Pharmacology, Louisiana State University, New Orleans, Louisiana.
r. Rothstein is currently a Senior Imaging Scientist, Integrative Biology, Eli Lilly
nd Company, Indianapolis, Indiana. Supported by National Institutes of Health
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Manuscript received March 28, 2006; revised manuscript received May 25, 2006,
ccepted June 19, 2006.ecause end-systolic stress is normal in a compensated
olume overload (1,2). During the compensated phase of
olume overload, forward cardiac output is maintained by a
reater-than-normal fractional shortening and stroke vol-
me (2). In fact, normal or slightly reduced fractional short-
See page 822
ning and/or an increase in the LVEDD/wall thickness is
ssociated with a poor outcome in patients with volume
verload caused by mitral or aortic valvular regurgitation (2).
ardiomyocyte elongation and dysfunction are accepted as
rucial events during the LV remodeling and decompensation
esponse to volume overload (1).
Angiotensin-converting enzyme (ACE) inhibitors are
idely used to treat heart failure; however, there is emerging
vidence showing that ACE inhibitors do not effectively
ttenuate eccentric remodeling during pure volume overload.
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Left Ventricular Remodeling in Volume Overload February 20, 2007:811–21In addition to converting angio-
tensin I to angiotensin II, ACE
binds and cleaves bradykinin
(BK) to inactive fragments with
an affinity several-fold greater
than that for angiotensin I (3).
We previously showed an in-
crease in LV interstitial fluid BK
during the volume overload of
aortocaval fistula (ACF) that is
further increased by ACE inhi-
bition (4). Bradykinin has been
shown to decrease collagen pro-
duction and increase matrix
metalloproteinase (MMP) expres-
sion in cultured fibroblasts (5–7).
We hypothesized that the antifi-
brotic response in acute volume
overload, leading to adverse LV
remodeling and dysfunction, in-
dependent of cardiomyocyte re-
modeling, is directly mediated by
BK. Here we show that the crit-
ical early event in LV remodeling
and dysfunction is BK-mediated
dissolution of the collagen ma-
trix, and not cardiomyocyte elon-
ation. Additionally, chronic ACE inhibition does not
ttenuate LV remodeling or improve systolic function dur-
ng volume overload, explaining why ACE inhibitors, which
ncrease antifibrotic BK, are ineffective in the treatment of
olume overload.
ethods
nimal preparation. Abdominal ACF was performed in
ale Sprague-Dawley rats (200 to 250 g) as previously
escribed (4). Age-matched sham- and ACF-operated rats
ere generated for echocardiographic and hemodynamic
tudy at 12 h; 2 and 5 days; and 4, 8, and 15 weeks, after
hich time they were killed and tissues were collected for
orphometry, immunohistochemistry, and protein analysis
n values given in Table 1). A separate group of rats was
illed at similar time points for isolated myocyte studies
n values given in Table 2). In a third group of animals, the
K receptor type 2 (BK2R) antagonist Hoe 140 (0.5
g/kg/day, subcutaneous, Sigma/RBI, Natick, Massachu-
etts) was started after ACF or sham surgery, and animals
ere killed at 2 days (n values given in Table 3). A subset of
ats (n  8) was treated with angiotensin II (1 g/kg/min,
smotic mini-pump, Bachem Bioscience Inc., King of
russia, Pennsylvania) for 2 days after ACF to generate a
lood pressure increase similar to that with ACF  Hoe
40. In a final group, the ACE inhibitor was started in
he drinking water (ramipril at 10 mg/kg/day, Hoechst,
Abbreviations
and Acronyms
ACE  angiotensin-
converting enzyme
ACF  aortocaval fistula
BK  bradykinin
BK2R  BK receptor type 2
LV  left ventricle/
ventricular
LVED  left ventricular
end-diastolic
LVEDD  left ventricular
end-diastolic dimension
LVES  left ventricular
end-systolic
LVESD  left ventricular
end-systolic dimension
MAP  mean arterial
pressure
MMP  matrix
metalloproteinase
TIMP  tissue inhibitor of
matrix metalloproteinase
VCFr  velocity of
circumferential shorteningrankfurt, Germany) after induction of ACF or sham, He T
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February 20, 2007:811–21 Left Ventricular Remodeling in Volume Overloadnd animals were killed at 4 weeks. Hemodynamic and
chocardiographic measurements were made on all drug-
reated animals. This protocol was approved by the
nimal Resource Program at the University of Alabama
t Birmingham.
emodynamic and echocardiographic measurements.
ats were anesthetized with ketamine (80 mg/kg intraperito-
eally) and xylazine (10 mg/kg intraperitoneally). High-fidelity
V pressures (SPR-249A Millar Mikro-Tip catheter trans-
ucer, Millar Instruments, Houston, Texas) were recorded
oncurrently with echocardiography (Agilent Sonos 5500,
hilips, Bothell, Washington). The LV wall stress and func-
ion were calculated as described previously (8).
ollagen analysis. Hearts were immersion fixed in 10%
uffered formalin, embedded in paraffin, sectioned at 3-m
hickness, and stained with picric acid Sirius red F3BA.
nterstitial collagen volume percent was evaluated with light
icroscopy at high power (40 objective, 1,220 video
creen magnification) in 30 to 40 randomly selected fields.
ollagen fiber thickness was measured using laser-confocal
mages (40 objective) of 15-m-thick sections and fluo-
escein isothiocyanate-labeled phalloidin. Image analysis
as performed using a line orthogonal grid overlay at 250
50 m for each field (approximately 5 fields per animal).
solated Cardiomyocyte Function in Age-Matched Sham and ACF R
Table 2 Isolated Cardiomyocyte Function in Age-Matched Sham
2-day 5-day
SHM ACF SHM ACF
Cell length* (m) 131 4 132 8 120 6 123 6
Shortening* (%) 11.5 0.6 13.4 0.8 10.5 0.9 11.4 0.8
dL/dt (m/s) 218 23 284 24 204 20 227 30
dL/dt (m/s) 295 25 348 44 244 24 282 35
Time to 50%
relaxation† (ms)
96 10 87 8 81 4 110 4†
n 7 6 7 9
alues are mean SEM. *Based on rank. †p  0.01 versus age-matched SHM.
dL/dt  change in length with time; other abbreviations as in Table 1.
Effect of Hoe 140 on Hemodynamic and EchocaMeasurements in Control Rats (2-Day SHM) and
Table 3 Effect of Hoe 140 on HemodynamicMeasurements in Control Rats (2-D
SHM Untreate
Heart rate* (beats/min) 259 6
MAP* (mm Hg) 75 2
LVEDP* (mm Hg) 1 0.1
LVESP (mm Hg) 55 3
LV  dP/dtmax* (mm Hg/s) 6,767 391
LV  dP/dtmax* (mm Hg/s) 4,698 152
LVEDD (mm) 6.9 0.2
LVESD* (mm) 4.0 0.2
LVEDD/wall thickness (mm/mm) 4.6 0.2
LV fractional shortening* (%) 41 2
Heart weight/body weight* (g/g  103) 3.3 0.0
n 7
Values are mean SEM. *Based on variance component analysis. †p
LVED  left ventricular end-diastolic; LVEDD  left ventricular end-dleft ventricular end-systolic; LVESD  left ventricular end-systolic dimension;
in Table 1.verage width was calculated at each grid intersection
oint.
dult rat LV myocyte isolation and measurement of
ingle-cell contractility. Left ventricular myocytes were
solated by cardiac retrograde aortic perfusion as previously
escribed (9), with minor modifications. Briefly, hearts from
nesthetized rats (phenobarbital 50 mg/kg intraperitoneally)
ere rapidly dissected and perfused using a Langendorf
pparatus with Kreb’s buffer (NaCl 118 mM, KCl 4.7 mM,
aHCO3 25 mM, Ca Cl2 1.8 mM, Mg2SO4 1.2 mM,
H2PO4 1.2 mM, glucose 11), followed by Ca
2-free
reb’s buffer, and Ca2 free-Kreb’s buffer containing 100
/ml type II collagenase (Worthington Biochemical, Lake-
ood, New Jersey). Left ventricular tissue was isolated and
urther digested in collagenase/body surface area (BSA)
reb’s buffer containing 25 M CaCl2. The resulting cells
ere resuspended in perfusion buffer with 3% BSA, in
hich the concentration of CaCl2 was stepwise increased to
mM. Rod-shaped cells were resuspended in Medium199
Sigma, St. Louis, Missouri) supplemented with 5 mM
reatine, 2 mM L-carnitine, and 5 mM taurine and plated
n laminin-coated glass coverslips.
Following two 1-h incubation periods, with medium
hanged between hours, coverslips were placed in a perfu-
ACF Rats
4-week 8-week 15-week
M ACF SHM ACF SHM ACF
 2 144 4 146 4 162 4† 143 4 176 5†
 0.7 13.5 0.9 11.8 0.5 11.6 0.7 12.6 0.9 9.8 0.7
 11 263 24 241 17 279 20 231 19 239 19
 35 381 37 301 20 358 28 313 31 292 25
 9 100 7 103 7 94 4 130 8 119 7
9 13 15 15 16 18
raphics 2 Days After ACF
Echocardiographic
M) and Rats 2 Days After ACF
CF Untreated SHM  Hoe 140 ACF  Hoe 140
296 7† 311 19 280 25
71 2 98 4†‡ 90 10
6 1 7 2† 7 1
55 2 76 3†‡ 76 7†‡
7,463 199 9,902 1,006† 9,814 1,353
4,932 117 7,160 826† 6,087 1,118
8.0 0.2† 6.8 0.3‡ 7.3 0.3
4.1 0.2 3.1 0.4 3.2 0.4
6.0 0.3† 4.1 0.4‡ 4.8 0.4
49 1† 55 4† 57 4
3.7 0.1† 3.4 0.1‡ 3.4 0.1‡
8 7 6
08 ( 0.05/6) versus SHM. ‡p  0.008 versus ACF.
dimension; LVEDP  left ventricular end-diastolic pressure; LVES ats
and
SH
134
11.1
195
297
114rdiogRat
and
ay SH
d A
 0.0
iastolicLVESP  left ventricular end-systolic pressure; other abbreviations as
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Left Ventricular Remodeling in Volume Overload February 20, 2007:811–21ion chamber with internal stimulating platinum electrodes
Warner Instruments, Hamden, Connecticut) attached to a
rass stimulator, and imaged using an inverted microscope
Olympus America Inc, Melville, New York) and CCD
amera (Philips, Andover, Massachusetts). A rod-shaped
ell without blebbing or spontaneous contractions was
hosen for imaging. The chamber was perfused with Tyrode
asic salt solution and paced (3-ms duration) for 2 min at a
tarting frequency of 0.5 Hz. The stimulating frequency was
tepwise increased from 0.5 to 3 Hz. The contractility of
ach cell was recorded with a video edge detection system
Crescent Electronics, Sandy, Utah) and analyzed using
igi-Med System Integrator Model 200/1 and Cell Data
nalysis software program (MicroMed Technology, Inc.,
ouston, Texas). At each frequency, data were analyzed
fter 1 min of pacing.
MP analysis. Left ventricular tissue was homogenized in
ysis buffer (0.2% Triton X-100, 10 g/ml aprotinin, 10
g/ml leupeptin, 0.5 mM PMSF, 500 M Na3VO4) and
entrifuged at 14,000 rpm for 10 min at 4°C. Protein
oncentrations were assessed with a bicinchonic acid assay.
estern blot analysis was performed with monoclonal anti-rat
MP-13, monoclonal anti-rat tissue inhibitor of MMP-1
TIMP-1), and rabbit polyclonal anti-rat TIMP-4 (all anti-
odies Chemicon, Temecula, California). Membranes were
ashed and treated with horseradish peroxidase-conjugated
econdary antibodies (goat anti-mouse or anti-rabbit immu-
oglobulin G). Immunoreactive bands were visualized using
nhanced chemiluminescence reagents exposed to Hyper-
lm at the linear range of film density. Films were scanned,
nd densitometric analysis was performed with National
nstitutes of Health image software.
tatistical analyses. All statistical analyses were done using
AS software (SAS Institute Inc., Cary, North Carolina).
eneralized linear models (two-factor with interaction and
ne-factor) were used to analyze all variables. We used the
olmogorov-Smirnov test and the Levene test on the residuals
o check normality and constancy of variance, respectively. If all
values for testing these assumptions were0.05, we consid-
red the model a good fit. Otherwise, we did a transformation
natural logarithm or ranks) and then chose the appropriate
ransformation that would resolve the assumption(s) violated.
roblems of non-normality and/or nonconstant variance of
he error terms were observed in a majority of the variables.
f transformations worked, p values for these goodness-
f-fit tests were all 0.10. Transformations applied to the
ariables are indicated in the tables and figures.
In a few variables, neither log nor rank transformation
emedied the goodness-of-fit problem observed. In these cases,
e used the Kruskal-Wallis test for 1-factor designs and
ariance component analyses (via SAS PROC MIXED) to
ccommodate the unequal variances across the factor combi-
ations for 2-factor designs. All tests were performed using a
% significance level. The Bonferroni method was used in the
air-wise comparisons for each variable to ensure an overall 5% tignificance level. Appropriate decision rules based on the
onferroni adjustment are indicated in the tables and figures.
esults
V remodeling in ACF. Twelve hours after the induc-
ion of volume overload, LVEDD had increased (p 
.05) by 20%, whereas LVEDD/wall thickness was
ncreased by 30% at 2 days after ACF (Figs. 1A and 1B).
here was no increase in cardiomyocyte length at either
ime (Fig. 1C). Both LVEDD and LVEDD/wall thick-
ess were increased by 40% at 4 to 15 weeks after ACF
Figs. 1A and 1B). Mean LV wall thickness decreased (p
0.05) at 15 weeks after ACF (Fig. 1D). Cardiomyocyte
ength increased by 9% and 18% above shams only at the
- and 15-week post-ACF time points, respectively (Fig.
C), whereas LV weight, which had increased by 40% at
weeks after ACF, did not increase further after this
oint (Fig. 1E).
Acutely, there was a 75% decrease in collagen volume
ercent 12 h after ACF that persisted at day 2 (Figs. 2A to
E). Collagen volume percent returned to sham values by 5
ays after ACF (Fig. 2D); however, the average diameter of
ollagen fibers at 5 days was increased compared with sham
Fig. 2F). Chronically, collagen volume percent was de-
reased 30% in ACF rats at 4, 8, and 15 weeks (data not
hown).
ndexes of systolic function in ACF. Mean arterial pres-
ure was decreased and heart rate increased both 12 h and 5
ays after induction of ACF, but did not differ from shams
t 4, 8, and 15 weeks after ACF (Table 1). Left ventricular
nd-systolic dimension (LVESD) did not differ from shams
t 12 h and 2 and 5 days after ACF. However, at 4 weeks
fter ACF, LVESD increased by 40% and remained ele-
ated in 8- and 15-week post-ACF rats despite the fact that
eft ventricular end-systolic (LVES) pressure did not differ
rom sham (Figs. 3A and 3B). Left ventricular fractional
hortening and velocity of circumferential shortening
VCFr) were not different from sham values until 15 weeks
fter ACF, when there was a decrease in VCFr concomitant
ith an increase in LVES stress (Figs. 3C to 3E). This
ecrease in VCFr occurred in the face of normal cardiomyocyte
ractional shortening and velocity of shortening (Table 2).
ndexes of diastolic function in ACF. Left ventricular
nd-diastolic (LVED) pressure and LVED wall stress (Figs.
A and 4B) were increased at 2 days and remained elevated
hroughout the time course, whereas lung wet weight (Fig.
C) was increased at 4 to 15 weeks and right ventricular
eight (Fig. 4E) was increased from 5 days after ACF
nward. Isolated cardiomyocyte relaxation velocity and time
o 50% relaxation did not differ in ACF and age-matched
hams across all time points, except at 5 days after ACF
Table 2), whereas LV  rate of left ventricular pressure
ecline (dP/dtmax) in ACF did not differ from shams at all
ime points (Table 1).
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February 20, 2007:811–21 Left Ventricular Remodeling in Volume Overloadoe 140 and LV remodeling and function in 2-day ACF
ats. Hoe 140 prevented the decrease in LV interstitial
ollagen (Fig. 5A) and the increase in LVEDD and
VEDD/wall thickness at 2 days after ACF (Table 3).
here was an increase in LVES pressure in both sham 
oe 140 and ACF  Hoe 140 rats (Table 3); however,
VES wall stress did not differ among all groups (data
Figure 1 LV Remodeling in Age-Matched Sham and ACF Rats
Left ventricular (LV) remodeling in aortocaval fistula (ACF) (open circles) at 12 h; 2
circles). Left ventricular end-diastolic dimension (LVEDD) (A), LVEDD/wall thickne
thickness (D), and LV wet weight (E). Alternating black and white boxes each rep
1 and 2 except: 4-week sham LVEDD, LVEDD/wall thickness, LVED wall thickness
sham echocardiographic parameters and LV wet weight (n  8); 15-week sham LV
( 0.05/6) for sham versus ACF at each time of the 6 time points except for isola
Analyses were based on ranks of all the variables in this figure.ot shown). Left ventricular fractional shortening was Hncreased in sham  Hoe 140 and ACF  Hoe 140
espite an increased left ventricular end-systolic pressure
ompared with untreated sham and ACF cases (Table 3).
eft ventricular weight/body weight did not increase in
ither ACF group; total heart weight/body weight in-
reased in ACF versus age-matched shams. In contrast,
otal heart weight/body weight did not increase in ACF 
5 days; and 4, 8, and 15 weeks compared with age-matched shams (closed
, isolated cardiomyocyte length (C), left ventricular end-diastolic (LVED) wall
one 24-h period. Data are presented as mean  SEM, n values given in Tables
9); 4-week ACF echocardiographic parameters and LV wet weight (n  9); 8-week
eight (n  12); and 15-week ACF LV wet weight (n  9). *p  0.008
rdiomyocyte length, where p  0.01 ( 0.05/5) for each of the 5 time points.and
ss (B)
resent
(n 
wet w
ted caoe 140 versus shamHoe 140 and sham rats (Table 3). At
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Left Ventricular Remodeling in Volume Overload February 20, 2007:811–21days after ACF, MMP-13 (rodent collagenase) was
ncreased, whereas TIMP-1 and -4 protein levels were not
ltered. Hoe 140 prevented the increase in MMP-13 but
ad no effect on TIMP-1 and -4 levels (Figs. 5B to 5D).
To assess whether the effects of Hoe 140 were through
direct mechanism on the heart or an indirect mecha-
ism through increased blood pressure, we infused an-
iotensin II and achieved a similar increase in MAP as
een with Hoe 140 infusion (Table 4). In comparison
ith ACF alone, angiotensin II partially prevented the
ecrease in collagen and the increase in LVEDD/wall
Figure 2 Representative Examples of LV Interstitial
Collagen in Control and ACF Rats
Representative examples of LV interstitial collagen in control (CTL) (n  8) (A)
and ACF at 12 h (n  5) (B), 2 days (n  8) (C), and 5 days (n  4) (D).
Mean collagen volume percent in 2-day CTL vs. ACF at 12 h, 2 days, and 5
days, where *p  0.0167 ( 0.05/3) using variance component analysis (E).
Mean collagen fiber width at 5 days of ACF versus CTL (F) where *p  0.05
using t test. Data are presented as mean  SEM. Abbreviations as in Figure 1.hickness. However, there was an increase in cardiac iypertrophy in ACF  angiotensin II when compared
ith the ACF  Hoe 140 (Table 4).
ffect of ramipril on LV remodeling and function in
-week ACF rats. Ramipril decreased LVES pressure and
eart weight/body weight in 4-week post-ACF rats. How-
ver, the decrease in LVES pressure was not accompanied
y an improvement in fractional shortening, LV dilation,
nd LVEDD/wall thickness (Table 5). Ramipril was asso-
iated with a further decrease in LV interstitial collagen
ompared with untreated ACF (Fig. 6).
iscussion
he current study provides new insights into the mech-
nism of eccentric remodeling in response to the volume
verload of ACF by combining LV chamber, cardiomy-
cyte, and interstitial collagen analyses. First, the critical,
ery early event (12 h to 2 days) in LV remodeling is
K-mediated dissolution of the collagen matrix, and not
longation of the cardiomyocyte. Second, further adverse
V remodeling and LV dysfunction are seen at the
-week stage of volume overload in the presence of
ormal cardiomyocyte shape and function. Third, treat-
ent with ACE inhibitor in the first 4 weeks after ACF
oes not attenuate LV remodeling or improve function
nd further decreases collagen relative to ACF alone.
hese findings explain why ACE inhibitors, which in-
rease antifibrotic BK, are ineffective in attenuating LV
emodeling in a pure volume overload.
K-mediated collagen dissolution exacerbates acute LV
emodeling. Important sequential changes in LV cham-
er and cardiomyocyte remodeling with ACF are shown
n Figure 1. Within 2 days, there is an increase in
VEDD and LVEDD/wall thickness with no change in
ardiomyocyte length. At the same time, there is a
arked decrease in interstitial collagen, showing that
ardiomyocyte elongation is not the earliest step in LV
ccentric remodeling in response to volume overload.
his rapid decrease in interstitial collagen is likely to be
ultifactorial. Simple stretch of cardiac fibroblasts in
itro increases collagenase activity (10) and membrane
ype 1-MMP expression (11). In addition, we and others
ave found an increase in mast cells and BK in this early
hase of ACF (4,12). Mast cell secretory products such as
rypsin, chymase, stromelysin (MMP-3), and cytokines,
uch as tumor necrosis factor-, are potent in vitro
ctivators of MMPs (13–16). Inhibition of ACE in ACF
ats significantly increased interstitial fluid BK but did
ot attenuate increases in mast cell density, which was
locked by the addition of BK2R blockade, supporting
he role of BK as an inflammatory mediator (4).
In addition to its effects on inflammatory cell recruit-
ent, BK decreases collagen I and III mRNA production
n cardiac fibroblasts (5), modulates MMP activation
hrough the plasminogen activator system (17), and
ncreases MMP-2 (6) and MMP-9 (7) expression. Two
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ncreased in the absence of changes in TIMP-1 and -4
evels (Fig. 5) and collagen I and III expression (data not
hown), suggesting that the decrease in interstitial colla-
en is caused by increased degradation, but not decreased
ynthesis. This acute loss of collagen in ACF stands in
tark contrast to a marked increase in collagen synthesis
hat has been reported after 2 days of acute pressure
verload in the rat (18). Thus, an acute inflammatory
Figure 3 Indexes of LV Systolic Function in Age-Matched Sham
Left ventricular (LV) function in ACF (open circles) at 12 h; 2 and 5 days; and 4, 8
end-systolic (LVES) pressure (A), left ventricular end-systolic dimension (LVESD) (B
cumferential shortening (VCFr) (E). Alternating black and white boxes each repres
except: 4-week sham LVESD, LV fractional shortening, and LV VCFr (n  9); 8-wee
sham versus ACF at each of the 6 time points. Analyses for left ventricular end-sy
ses for LV fractional shortening and LVES  were based on their natural logarithmesponse [increased BK and mast cell density (4)] coupled bith a stretch stimulus, which occurs in the absence of
ressure overload, may induce a rapid loss of the collagen
atrix.
Blockade of BK2R prevents an increase in MMP-13 and
decrease of interstitial collagen, and normalizes LVEDD/
all thickness at 2 days of ACF stress. Further, LVES
ressure increases as LVESD trends down 25% vs. un-
reated ACF rats (Table 3), suggesting that BK2R blockade
mproves LV function. This functional improvement could
ACF Rats
15 weeks compared with age-matched shams (closed circles). Left ventricular
fractional shortening (FS) (C), LVES wall stress () (D), and LV velocity of cir-
e 24-h period. Data are presented as mean  SEM, n values given in Table 1
LVESD, LV fractional shortening, and LV VCFr (n  8). *p  0.008 ( 0.05/6)
ressure (LVESP), LVESD, and LVVCFr were based on their ranks, whereas analy-and
, and
), LV
ent on
k sham
stolic p
s.e a consequence of more efficient transmission of forces
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reservation of the matrix. Interestingly, antagonism of
K2R in ACF animals is associated with a decrease in
ardiac hypertrophy despite the increase in MAP. To test
hether the local cardiac effects of BK2R blockade are
mportant, or whether functional and remodeling improve-
ents during ACF are attributable to the increase in blood
ressure caused by BK2R blockade, we examined the effect
f a hypertensive challenge that was similar in magnitude to
hat seen with Hoe 140 treatment. Using angiotensin II
nfusion, we achieved an increase in blood pressure at 2 days
fter ACF equivalent to that seen with Hoe 140 treatment.
imilar to Hoe 140, angiotensin II increased collagen matrix
nd normalized LVEDD/wall thickness compared with
CF alone; unlike Hoe 140, it also increased cardiac
ypertrophy. Because BK is upregulated acutely in the LV
uring ACF, it is tempting to speculate that its blockade in
he heart prevents the loss of collagen through a direct
echanism rather than through an indirect effect on blood
ressure.
At 5 days after ACF, the collagen volume percent returns
o normal; however, this rebound is abnormal because there
Figure 4 Indexes of Diastolic LV Remodeling in Age-Matched S
Indexes of diastolic LV remodeling in ACF (open circles) at 12 h; 2 and 5 days; an
sure (A), LVED wall stress () (B), lung wet weight (C), and right ventricular (RV) w
Data are presented as mean  SEM, n values given in Table 1 except: 4-week sh
weight (n  8); 4-week ACF lung wet weight and RV wet weight (n  9); 8-week sh
wet weight (n  12); and 15-week ACF lung wet weight and RV wet weight (n  9)
were based on ranks of all the variables in this figure. Abbreviations as in Figure 1re fewer collagen fibers and these fibers are thicker than tormal (Fig. 2). This rebound in collagen occurs in the
bsence of an increase in MAP, and may also be a response
o a local increase in cardiac interstitial angiotensin II (4).
he change in collagen structure could be a temporary
daptive response because it is associated with a cessation of
urther LV dilation at 5 days. However, at 4 weeks after
CF there is a subsequent decrease in extracellular matrix
nd a marked increase in LVEDD/wall thickness.
dverse LV remodeling and dysfunction in chronic
olume overload. Another important finding of this study
s that LV systolic and diastolic dysfunction (4 to 15 weeks)
s not related to cardiomyocyte dysfunction. There is evi-
ence of LV systolic dysfunction as early as the 4-week stage
f ACF (Fig. 3), manifested by an increase in LVESD,
hereas LV fractional shortening does not increase despite
n increase in preload and normal LVES wall stress. At 4
eeks after ACF, LVESD is increased in the presence of
ormal LVES pressure, resulting in a significant increase in
VES wall stress at 15-week ACF. It is also important to
ote that there is no incremental increase in LV hypertro-
hy 4 weeks after induction of ACF, despite an increase in
VES wall stress at 15 weeks. In addition, ACF LV wall
and ACF Rats
, and 15 weeks compared with age-matched shams (closed circles). LVED pres-
ight (D). Alternating black and white boxes each represent one 24-h period.
ED pressure and LVED  (n  5); 4-week sham lung wet weight and RV wet
g wet weight and RV wet weight (n  8); 15-week sham lung wet weight and RV
0.008 ( 0.05/6) sham versus ACF at each of the 6 time points. Analysesham
d 4, 8
et we
am LV
am lun
. *p 
.hickness is decreased and cardiomyocytes are elongated at
1
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nd contributing to a decrease in LV VCFr, all in the face
f normal cardiomyocyte function. At a similar ACF time
oint, Wang et al. (19) found enhanced LV 1-receptor
Figure 5 Indexes of Collagen Homeostasis in Hoe 140-Treated
Collagen volume percent (A), matrix metalloproteinase (MMP)-13 (B), tissue inhib
sham (SHM) and ACF rats with and without Hoe 140 treatment. Data are presente
†p  0.008 versus ACF. Collagen volume and MMP-13 were analyzed via variance
ations as in Figure 1.
Hemodynamic and Morphometric Parameters inUntreated ACF, 2-Day ACF  Hoe 140, and 2-Da
Table 4 Hemodynamic and Morphometric PaUntreated ACF, 2-Day ACF  Hoe 1
ACF Un
Heart rate* (beats/min) 296
MAP* (mm Hg) 71
LVEDP (mm Hg) 5
LVEDD (mm) 8.0
LV posterior wall thickness (mm) 1.3
LVESD* (mm) 4.1
LVEDD/wall thickness (mm/mm) 6.0
LV fractional shortening (%) 49
Heart weight/body weight (g/g  103) 3.7
Collagen volume % 2.1
n 8Values are mean  SEM. *Based on ranks. †p  0.0167 ( 0.05/3) versus
Ang II  angiotensin II; other abbreviations as in Tables 1 and 3.ensity and increased basal activity. Thus, the disparity
etween isolated myocyte function in vitro and LV chamber
unction in vivo could be caused by loss of collagen
tructural support.
and ACF Rats
matrix metalloproteinase (TIMP)-1 (C), and TIMP-4 (D) levels at 2 days in
ean  SEM, n values given in Table 3. *p  0.008 ( 0.05/6) versus SHM;
onent, whereas TIMP-1 and -4 were analyzed using a Kruskal-Wallis test. Abbrevi-
yF  Ang II
ters in 2-Day
nd 2-Day ACF  Ang II
ACF  Hoe 140 ACF  Ang II
280 62 308 10
90 10 91 5†
7 1 9 2
7.3 0.3 7.8 0.4
1.6 0.1 1.8 0.1†
3.2 0.4 3.7 0.2
4.8 0.4 4.4 0.4†
57 4 51 3
3.4 0.1† 4.0 0.1‡
4.1 0.3† (n 8) 3.2 0.3†‡
6 8Sham
itor of
d as m
comp2-Day AC
rame
40, a
treated
19
2
1
0.2
0.1
0.2
0.3
1
0.1
0.1ACF untreated. ‡p  0.0167 versus ACF  Hoe 140.
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Left Ventricular Remodeling in Volume Overload February 20, 2007:811–21Left ventricular end-diastolic pressure and wall stress
re elevated as early as 2 days after ACF and throughout
he entire time course (Fig. 4). Lung wet-weight is also
ncreased, indicative of decreased LV compliance despite
he decrease in interstitial collagen and normal indexes of
ardiomyocyte relaxation throughout 15 weeks after ACF
Table 2). Previous studies in ACF rats at 6 weeks
howed an increase in collagen cross-linkage and no
hange in collagen content, resulting in a stiffer LV
hamber (20). Thus, a simple assessment of collagen
ontent without regard to collagen cross-linking or sub-
ype distribution, especially in volume overload, could
bscure changes in chamber compliance. Our results
uggest that the progressive LV remodeling and systolic
Figure 6 Volume Percent of Collagen in
Ramipril-Treated Sham and ACF Rats
Collagen volume percent in 4-week sham (SHM) and aortocaval fistula (ACF),
4-week sham  ramipril, and 4-week ACF  ramipril. Data are presented as
mean  SEM, n values given in Table 5. *p  0.008 ( 0.05/6) versus
sham, †p  0.008 versus ACF, ‡p  0.008 versus sham  ramipril. Variance
components analysis was used.
ffect of RAM on Hemodynamic and Echocardiographiceasurements i Control Rats (4-Week SHM) and Rats After 4 We
Table 5 Effect of RAM on Hemodynamic and EchocardiographicMeasurements in Control Rats (4-Week SHM) and Rat
SHM Untreated
Heart rate* (beats/min) 260 18
MAP (mm Hg) 114 10
LVEDP (mm Hg) 6 1 (n 5)
LVESP (mm Hg) 100 10
LV  dP/dtmax (mm Hg/s) 7,989 342
LV  dP/dtmax (mm Hg/s) 6,393 417
LVEDD (mm) 7.5 0.1 (n 9)
LVESD‡ (mm) 4.2 0.3 (n 9)
LVEDD/wall thickness‡ (mm/mm) 3.9 0.3 (n 9)
LV fractional shortening‡ (%) 44 4 (n 9)
Heart weight/body weight (g/g  103) 3.1 0.1 (n 8)
n 6
alues are mean  SEM. *Based on Kruskal-Wallis test. †p  0.008 ( 0.05/6) versus SHM. ‡B
RAM  ramipril; other abbreviations as in Tables 1 and 3.tysfunction, which is disproportionate to cardiomyocyte
emodeling, results from dissolution of the collagen
atrix.
hronic ACE inhibition does not attenuate LV remod-
ling in volume overload. We found that ACE inhibi-
ion increased collagen loss at 4 weeks after ACF (Fig. 6)
nd did not attenuate adverse LV chamber remodeling as
ummarized in Table 5. With ACF  ACE inhibitor
reatment, LVEDD/wall thickness and LVED wall stress
emained elevated and LVESD increased relative to
CF-untreated rats, even though there was a decrease in
VES pressure and cardiac hypertrophy. The failure to
mprove LV remodeling and function may be caused by
n ACE inhibitor-induced loss of supporting collagen
tructure that results in further cardiomyocyte elongation.
ur BK2R blockade studies suggest that ACE inhibitor-
nduced increase in BK contributes to the acute adverse
emodeling seen in volume overload after ACF. How-
ver, we do not show the role of long-term BK2R
ctivation in the heart on the volume overloaded LV, and
herefore, the mechanism of the long-term deleterious
ffects of chronic ACE inhibition remains uncertain. We
ave shown a similar loss of collagen and MMP activity
n early and late phases of mitral regurgitation in the dog
21). Indeed, ACE inhibitor or angiotensin II receptor
lockade failed to attenuate LV remodeling in dogs with
itral regurgitation (8,22), and we have shown that such
herapy results in further cardiomyocyte elongation (8).
inally, ACE inhibitor or angiotensin II receptor block-
de have not been shown to be beneficial in patients with
ure volume overload due to valvular regurgitation (2).
ummary. Here we show that an increase in LVEDD/
all thickness, previously thought to be caused by myo-
yte elongation, may have less to do with myocyte length
nd more to do with matrix changes that affect the
ollagen scaffolding connecting individual myocytes and
ollections of myocytes that comprise the laminar struc-
f ACF
er 4 Weeks of ACF
ACF Untreated SHM  RAM ACF  RAM
291 7 (n 8) 282 12 299 5
94 6 (n 8) 108 7 83 4†
13 1 (n 7) 12 2 13 2
82 5 (n 8) 91 8 64 5†
7,956 332 (n 7) 7,607 278 7,464 166
5,491 503 (n 7) 6,067 258 5,452 254
9.9 0.2† 7.7 0.2 9.4 0.5
5.5 0.3† 5.1 0.3 5.5 0.5†
5.6 0.3† 4.7 0.2 6.1 0.5†
44 2 34 3 43 3
4.9 0.2† 2.5 0.1§ 4.0 0.2†§
9 6 7
ranks. §p  0.008 versus ACF. p  0.008 versus SHM  RAM.eks o
s Afture of the heart (23). We also show that the BK-
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February 20, 2007:811–21 Left Ventricular Remodeling in Volume Overloadediated change in the extracellular matrix is an early
vent that sets in motion adverse LV remodeling and
unction. This study has important implications for the
K-enhancing effects of ACE inhibitor therapy in pure
olume overload states. The role of matrix degradation in
olume overload challenges current concepts regarding
he pathophysiology of eccentric LV remodeling and
xplains why ACE inhibitors are effective at reversing LV
emodeling during pressure overload but are ineffective in
reating volume overload.
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